+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of hormone replacement therapy on the activities of factor VII and protein C in postmenopausal women women The postmenopausal estrogen/progestin intervention trial



Effect of hormone replacement therapy on the activities of factor VII and protein C in postmenopausal women women The postmenopausal estrogen/progestin intervention trial



Blood 86(10 Suppl. 1): 200A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031087754

Download citation: RISBibTeXText


Related references

Effects of hormone replacement therapy on endometrial histology in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA (Journal of the American Medical Association) 275(5): 370-375, 1996

The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial. Atherosclerosis 185(2): 347-352, 2005

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 275(5): 370-375, 1996

Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: The Postmenopausal Estrogen/Progestins Interventions (PEPI) trial. Journal of Clinical Epidemiology 52(12): 1187-1195, 1999

Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Journal of Women's Health and Gender-Based Medicine 8(9): 1167-1172, 1999

How many women lose bone mineral density while taking hormone replacement therapy? Results from the Postmenopausal Estrogen/Progestin Interventions Trial. Archives of Internal Medicine 160(20): 3065-3071, 2000

Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 287(5): 591-597, 2002

Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. Journal of Clinical Endocrinology and Metabolism 88(4): 1646-1652, 2003

Canadian consensus on hormone replacement therapy. Estrogen and progestin use in postmenopausal women. Canadian Family Physician Medecin de Famille Canadien 49: 188-191, 2003

The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 44(4): 811-818, 2001

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA (Journal of the American Medical Association) 273(3): 199-208, 1995

Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?. Journal of Family Practice 50(5): 470, 2001

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 273(3): 199-208, 1995

Guidance For Clinical Evaluation Of Combination Estrogen/Progestin-Containing Drug Products Used For Hormone Replacement Therapy (Hrt) Of Postmenopausal Women. Menopause 3(2): 117-118, 1996

Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women. Acta Obstetricia Et Gynecologica Scandinavica. 77(3): 330-333, Ch, 1998